• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探讨在生存时间设定下不同一致性测量指标的适宜性。

Investigating the appropriateness of different concordance measures in a time-to-event setting.

机构信息

Mathematics & Statistics, McMaster University, Hamilton, Canada.

Department of Oncology, McMaster University, Hamilton, Canada.

出版信息

Pharm Stat. 2020 Nov;19(6):763-775. doi: 10.1002/pst.2029. Epub 2020 May 21.

DOI:10.1002/pst.2029
PMID:32436263
Abstract

PURPOSE

Prediction models that assess a patient's risk of an event are used to inform treatment options and confirm screening tests. The concordance (c) statistic is one measure to validate the accuracy of these models, but has many extensions when applied to censored data. The purpose was to determine which c-statistic is most accurate at different rates of censoring.

METHODS

A simulation study was conducted for n = 750, and censoring rates of 20%, 50%, and 80%. The mean of three different concordance definitions were compared as well as the mean of three different c-statistics, including one, parametric c-statistic for exponentially distributed data, developed by the authors. The SE was also calculated but was of secondary interest.

RESULTS

The c-statistic developed by the authors yielded the a mean closest to the gold standard concordance measure when censoring is present in data, even when the exponentially distributed parametric assumptions do not hold. Similar results were found for SE.

CONCLUSIONS

The c-statistic developed by the authors appears to be the most robust to censored data. Thus, it is recommended to use this c-statistic to validate prediction models applied to censored data. This will improve the reliability and comparability across future time-to-event studies.

摘要

目的

评估患者发生事件风险的预测模型用于为治疗方案提供参考并验证筛查试验。一致性(c)统计量是一种验证此类模型准确性的指标,但在应用于删失数据时,它有许多扩展。本研究旨在确定在不同删失率下哪种 c 统计量最准确。

方法

对 n = 750 例进行模拟研究,删失率分别为 20%、50%和 80%。比较了三种不同一致性定义的平均值以及三种不同 c 统计量的平均值,包括作者开发的适用于指数分布数据的参数 c 统计量。同时还计算了标准误,但这是次要关注点。

结果

当数据中存在删失时,作者开发的 c 统计量的平均值最接近金标准一致性测量值,即使指数分布的参数假设不成立。标准误也得到了类似的结果。

结论

作者开发的 c 统计量似乎对删失数据最稳健。因此,建议在应用于删失数据的预测模型验证中使用该 c 统计量。这将提高未来生存时间研究的可靠性和可比性。

相似文献

1
Investigating the appropriateness of different concordance measures in a time-to-event setting.探讨在生存时间设定下不同一致性测量指标的适宜性。
Pharm Stat. 2020 Nov;19(6):763-775. doi: 10.1002/pst.2029. Epub 2020 May 21.
2
Designing phase II studies in cancer with time-to-event endpoints.设计以事件发生时间为终点的癌症II期研究。
Clin Trials. 2008;5(3):209-21. doi: 10.1177/1740774508091748.
3
The inverse-probability-of-censoring weighting (IPCW) adjusted win ratio statistic: an unbiased estimator in the presence of independent censoring.逆概率删失加权(IPCW)调整后的赢率统计量:在独立删失存在下的无偏估计量。
J Biopharm Stat. 2020 Sep 2;30(5):882-899. doi: 10.1080/10543406.2020.1757692. Epub 2020 Jun 17.
4
Concordance indices with left-truncated and right-censored data.一致性指数与左截断和右删失数据。
Biometrics. 2023 Sep;79(3):1624-1634. doi: 10.1111/biom.13714. Epub 2022 Jul 11.
5
Addressing issues associated with evaluating prediction models for survival endpoints based on the concordance statistic.基于一致性统计量解决与评估生存终点预测模型相关的问题。
Biometrics. 2016 Sep;72(3):897-906. doi: 10.1111/biom.12470. Epub 2016 Jan 12.
6
On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data.基于删失生存数据评估风险预测方法整体充分性的 C 统计量。
Stat Med. 2011 May 10;30(10):1105-17. doi: 10.1002/sim.4154. Epub 2011 Jan 13.
7
Consistent estimation of the expected Brier score in general survival models with right-censored event times.在具有右删失事件时间的一般生存模型中对预期Brier评分进行一致估计。
Biom J. 2006 Dec;48(6):1029-40. doi: 10.1002/bimj.200610301.
8
Monitoring event times in early phase clinical trials: some practical issues.早期临床试验中的事件时间监测:一些实际问题。
Clin Trials. 2005;2(6):467-78. doi: 10.1191/1740774505cn121oa.
9
Bayesian optimal phase II clinical trial design with time-to-event endpoint.贝叶斯最优设计的Ⅱ期临床试验设计,以时间为终点事件。
Pharm Stat. 2020 Nov;19(6):776-786. doi: 10.1002/pst.2030. Epub 2020 Jun 10.
10
Review and evaluation of performance measures for survival prediction models in external validation settings.外部验证环境下生存预测模型性能指标的回顾与评估
BMC Med Res Methodol. 2017 Apr 18;17(1):60. doi: 10.1186/s12874-017-0336-2.